Clinical trial

Prophylactic Antibiotic in Non-complicated Low Risk Laparoscopic Cholecystectomy; Is it Worthy? A Prospective Randomized Comparative Study.

NCT06193837

Name

Prophylactic Antibiotic in LC

Description

To Compare between outcomes of Antibiotic Prophylaxis and No antibiotic prophylaxis in non-complicated low risk laparoscopic cholecystectomy

Trial arms

Trial start

2024-01-01

Estimated PCD

2025-08-01

Trial end

2026-01-01

Status

Not yet recruiting

Treatment

Augmentin

Use of prophylactic antibiotics in lap cholecystectomy

Arms:

Group 1

Other names:

laparoscopy

Size

200

Primary endpoint

To compare between infection rate at both groups

Baseline

Hospitalization time

Baseline

Eligibility criteria

Inclusion Criteria: * Adult male and female at the Age of 18 years or above. * Symptomatic gall bladder stones. * Ultrasonography shows gall bladder stones. * Uncomplicated chronic calculous cholecystitis Exclusion Criteria: * Complicated gall bladder stones. * Malignant gall bladder mass * Laparoscopic cholecystectomy with Common Bile Duct (CBD) exploration. * Absolute contraindications to LC like cardiovascular, pulmonary disease, coagulopathies and end stage liver disease. * The cases of Laparoscopic Cholecystectomy conversion to Open Cholecystectomy due to equipment failure. * Immunocompromised patients as Uncontrolled DM, HIV and patients on certain medications as corticosteroids and chemotherapy.

Protocol

{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'RETROSPECTIVE'}, 'enrollmentInfo': {'count': 200, 'type': 'ESTIMATED'}}

Updated at

2024-01-05

1 organization

1 product

2 indications

Organization

Product

Indication

Indication